{"id":"NCT00035932","sponsor":"Bristol-Myers Squibb","briefTitle":"Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV","officialTitle":"Phase III Open Label Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2001-11","primaryCompletion":"2003-07","completion":"2009-03","firstPosted":"2002-05-08","resultsPosted":"2010-12-24","lastUpdate":"2010-12-24"},"enrollment":571,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["HIV Infections"],"interventions":[{"type":"DRUG","name":"Atazanavir + ritonavir + tenofovir + nucleoside","otherNames":["BMS-232632","Reyataz"]},{"type":"DRUG","name":"Atazanavir + saquinavir + tenofovir + nucleoside","otherNames":["BMS-232632","Reyataz"]},{"type":"DRUG","name":"Lopinavir/ritonavir + tenofovir + nucleoside","otherNames":[]}],"arms":[{"label":"I","type":"ACTIVE_COMPARATOR"},{"label":"II","type":"ACTIVE_COMPARATOR"},{"label":"III","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to learn how well atazanavir (ATV) works in combination with ritonavir (RTV) or saquinavir (SQV) with tenofovir (TDF) and a nucleoside to reduce the viral load of treatment experienced subjects with human immunodeficiency virus (HIV). There is a comparison arm with lopinavir (LPV)/RTV and TDF and a nucleoside.","primaryOutcome":{"measure":"Mean Change From Baseline in HIV Ribonucleic Acid (RNA) at Week 24","timeFrame":"Baseline, Week 24","effectByArm":[{"arm":"ATV 300 mg / RTV","deltaMin":-1.86,"sd":0.11},{"arm":"ATV 400 mg / SQV","deltaMin":-1.52,"sd":0.13},{"arm":"LPV / RTV","deltaMin":-1.89,"sd":0.11}],"pValues":[{"comp":"OG000 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null}]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":15},"locations":{"siteCount":29,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":22,"n":119},"commonTop":["DIARRHOEA","HEADACHE","NAUSEA","INFLUENZA","NASOPHARYNGITIS"]}}